Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jake Simson currently holds 15,500 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jake Simson has been a net neutral trader of JANX stock. They have purchased $0 and sold $0 worth of shares.
Jake Simson's most recent insider trade was on Jun 11, 2026, when they sold 15,500 shares at $0.00 per share.
Jake Simson serves as Executive at Janux Therapeutics, Inc. (JANX). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Jake Simson holds the position of Executive at Janux Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Jake Simson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jake Simson was on Jun 11, 2026, when they purchased $0 worth of JANX shares. This transaction involved 15,500 shares at N/A per share.
Jake Simson currently owns 15,500 shares of Janux Therapeutics, Inc. (JANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jake Simson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jake Simson has 7 Form 4 filings on record as an insider at Janux Therapeutics, Inc..
Set alerts for Jake Simson and 40,000+ other insiders.